| Deryck A Joseph, MD | |
|
832 Princeton Ave Sw, Birmingham, AL 35211-1320 | |
| (205) 206-8470 | |
| (205) 206-8390 |
| Full Name | Deryck A Joseph |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 36 Years |
| Location | 832 Princeton Ave Sw, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679515159 | NPI | - | NPPES |
| 009944905 | Medicaid | AL | |
| 510-25542 | Other | AL | BCBS OF AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 19217 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| St Vincent's Birmingham | Birmingham, AL | Hospital |
| Shelby Baptist Medical Center | Alabaster, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vincentian Physician Services Llc | 1557548161 | 76 |
| Baptist Health Centers Llc | 3476457011 | 156 |
| G I Associates Of West Alabama Pc | 4082654314 | 15 |
| Dch Provider Services Llc | 6800150517 | 5 |
News Archive
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the two double blind, randomized, placebo controlled, Phase 3 clinical trials for apaziquone did not meet their primary endpoint of a statistically significant difference in the rate of tumor recurrence at 2 years between the two arms.
"Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said Monday, adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health," the U.N. News Centre reports.
A team of Canadian dermatologists have reviewed the latest evidence surrounding sunscreen use to conclude key points regarding its use and efficacy.
› Verified 8 days ago
| Entity Name | G I Associates Of West Alabama Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316985757 PECOS PAC ID: 4082654314 Enrollment ID: O20050505001172 |
News Archive
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the two double blind, randomized, placebo controlled, Phase 3 clinical trials for apaziquone did not meet their primary endpoint of a statistically significant difference in the rate of tumor recurrence at 2 years between the two arms.
"Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said Monday, adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health," the U.N. News Centre reports.
A team of Canadian dermatologists have reviewed the latest evidence surrounding sunscreen use to conclude key points regarding its use and efficacy.
› Verified 8 days ago
| Entity Name | Vincentian Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851698310 PECOS PAC ID: 1557548161 Enrollment ID: O20110608000452 |
News Archive
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the two double blind, randomized, placebo controlled, Phase 3 clinical trials for apaziquone did not meet their primary endpoint of a statistically significant difference in the rate of tumor recurrence at 2 years between the two arms.
"Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said Monday, adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health," the U.N. News Centre reports.
A team of Canadian dermatologists have reviewed the latest evidence surrounding sunscreen use to conclude key points regarding its use and efficacy.
› Verified 8 days ago
| Entity Name | Baptist Health Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265496236 PECOS PAC ID: 3476457011 Enrollment ID: O20180124001442 |
News Archive
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the two double blind, randomized, placebo controlled, Phase 3 clinical trials for apaziquone did not meet their primary endpoint of a statistically significant difference in the rate of tumor recurrence at 2 years between the two arms.
"Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said Monday, adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health," the U.N. News Centre reports.
A team of Canadian dermatologists have reviewed the latest evidence surrounding sunscreen use to conclude key points regarding its use and efficacy.
› Verified 8 days ago
| Entity Name | Dch Provider Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982103974 PECOS PAC ID: 6800150517 Enrollment ID: O20180504001564 |
News Archive
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the two double blind, randomized, placebo controlled, Phase 3 clinical trials for apaziquone did not meet their primary endpoint of a statistically significant difference in the rate of tumor recurrence at 2 years between the two arms.
"Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said Monday, adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health," the U.N. News Centre reports.
A team of Canadian dermatologists have reviewed the latest evidence surrounding sunscreen use to conclude key points regarding its use and efficacy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deryck A Joseph, MD Po Box 12366, Birmingham, AL 35202-2366 Ph: (205) 780-7101 | Deryck A Joseph, MD 832 Princeton Ave Sw, Birmingham, AL 35211-1320 Ph: (205) 206-8470 |
News Archive
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the two double blind, randomized, placebo controlled, Phase 3 clinical trials for apaziquone did not meet their primary endpoint of a statistically significant difference in the rate of tumor recurrence at 2 years between the two arms.
"Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said Monday, adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health," the U.N. News Centre reports.
A team of Canadian dermatologists have reviewed the latest evidence surrounding sunscreen use to conclude key points regarding its use and efficacy.
› Verified 8 days ago
Juan Mario Bernal, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Gastroenterology Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |